160 related articles for article (PubMed ID: 15828234)
1. [PPARs and heart diseases].
Takano H; Komuro I
Nihon Rinsho; 2005 Apr; 63(4):659-64. PubMed ID: 15828234
[TBL] [Abstract][Full Text] [Related]
2. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
3. PPAR ligands: are they potential agents for cardiovascular disorders?
Balakumar P; Rose M; Singh M
Pharmacology; 2007; 80(1):1-10. PubMed ID: 17496434
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases.
Takano H; Hasegawa H; Zou Y; Komuro I
Curr Pharm Des; 2004; 10(22):2779-86. PubMed ID: 15320743
[TBL] [Abstract][Full Text] [Related]
5. The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy.
Takano H; Hasegawa H; Nagai T; Komuro I
Timely Top Med Cardiovasc Dis; 2005 Apr; 9():E10. PubMed ID: 15830032
[TBL] [Abstract][Full Text] [Related]
6. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
Alemán G; Torres N; Tovar AR
Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
[TBL] [Abstract][Full Text] [Related]
7. PPAR receptor activation: Experimental studies on cardiac structure and function.
Bishop-Bailey D
Curr Opin Investig Drugs; 2010 Mar; 11(3):283-8. PubMed ID: 20178041
[TBL] [Abstract][Full Text] [Related]
8. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
9. PPARs as therapeutic targets in cardiovascular disease.
van Bilsen M; van Nieuwenhoven FA
Expert Opin Ther Targets; 2010 Oct; 14(10):1029-45. PubMed ID: 20854178
[TBL] [Abstract][Full Text] [Related]
10. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.
Takano H; Komuro I
J Diabetes Complications; 2002; 16(1):108-14. PubMed ID: 11872377
[TBL] [Abstract][Full Text] [Related]
11. [PPARs, metabolic syndrome and cardiac diseases].
Carvajal K; Hernández-Esquivel Mde L; Moreno-Sánchez R
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-66-76. PubMed ID: 18938701
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
14. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
Bordet R; Ouk T; Petrault O; Gelé P; Gautier S; Laprais M; Deplanque D; Duriez P; Staels B; Fruchart JC; Bastide M
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1341-6. PubMed ID: 17073815
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors and the metabolic syndrome.
Bragt MC; Popeijus HE
Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and atherosclerosis.
Soskić SS; Dobutović BD; Sudar EM; Obradović MM; Nikolić DM; Zarić BL; Stojanović SD; Stokić EJ; Mikhailidis DP; Isenović ER
Angiology; 2011 Oct; 62(7):523-34. PubMed ID: 21467121
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
19. [PPAR and diabetes].
Terauchi Y; Kadowaki T
Nihon Rinsho; 2005 Apr; 63(4):623-9. PubMed ID: 15828230
[TBL] [Abstract][Full Text] [Related]
20. [Roles of PPARs in carcinogenesis].
Imamura K; Lu J; Kaminishi M
Nihon Rinsho; 2005 Apr; 63(4):584-8. PubMed ID: 15828224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]